Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma.
Hu H, Dong Z, Wang X, Bai L, Lei Q, Yang J, Li L, Li Q, Liu L, Zhang Y, Ji Y, Guo L, Liu Y, Cui H.
Hu H, et al. Among authors: li l, li q.
Onco Targets Ther. 2019 Jul 2;12:5163-5175. doi: 10.2147/OTT.S183558. eCollection 2019.
Onco Targets Ther. 2019.
PMID: 31456643
Free PMC article.